Equity-based Compensation - Schedule of Stock Option Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Weighted average exercise price
Aggregate intrinsic value, exercisable at end of year	$ 5,100,000	$ 6,000,000	$ 75,500,000
Stock options
Stock Options
Outstanding at beginning of the year (in shares)	2,470,463	2,969,963	7,375,000
Granted during the year (in shares)	0	0	0
Forfeited during the year (in shares)	(75,000)
Exercised during the year (in shares)	(736,463)	(499,500)	(4,405,037)
Outstanding at end of the year (in shares)	1,659,000	2,470,463	2,969,963	7,375,000
Exercisable at end of the year (in shares)	1,659,000	1,441,463	911,963
Weighted average exercise price
Weighted average exercise price, beginning (in dollars per share)	$ 10.97	$ 11.09	$ 11.38
Granted during the year (in dollars per share)	0
Forfeited during the year (in dollars per share)	10.00
Exercised during the year (in dollars per share)	11.80	11.70	11.57
Weighted average exercise price, ending (in dollars per share)	10.64	10.97	11.09	$ 11.38
Exercisable at end of year (in dollars per share)	$ 10.64	$ 11.03	$ 11.56
Weighted average remaining contractual term, outstanding	9 months 18 days	1 year 7 months 6 days	2 years 6 months	3 years 4 months 24 days
Weighted average remaining contractual term, exercisable at end of year	9 months 18 days	1 year 6 months	2 years 3 months 18 days
Aggregate intrinsic value, outstanding	$ 14,128,440	$ 23,746,573	$ 43,091,497
Aggregate intrinsic value, exercisable at end of year	$ 14,128,440	$ 13,767,753	$ 12,802,697